Frontiers has published the latest clinical data of AB-KOLICARE™, that shows quite promising results on infant colic. This probiotic formulation leads AB-BIOTICS pediatric line, containing two bacteria strains with a battery of benefits for babies.
A newly published clinical trial in Gut Microbes – a top journal reporting the latest science in microbiota – has confirmed that Kaneka Group / AB-Biotics’ AB21 probiotic formulation exhibits significant positive effects in COVID-19 outpatients.
AB-BIOTICS SA
Av. Torre Blanca 57
ESADE Creapolis Building
Sant Cugat del Valles
08172 Spain
(+34) 935 803 876
Kaneka Americas Holding, Inc.
Probiotics Division
7979 Gateway Boulevard
Newark (California)
94560 United States
AB-BIOTICS Pte Ltd
10 Anson Road #12-14
International Plaza
Singapore 079903
